NASDAQ : LPTX

Leap Therapeutics, Inc. — Earnings Estimates

$0.7696 USD

-$0.03 (-3.15%)

Volume
848.47K
Average Volume
22.41M
Market Capitalization
$31.86M
P/E Ratio
1.20
Dividend Yield
0.00%
Price Target
$5.50
Year High
$3.58
Year Low
$0.22
Day High
Day Low
Payout Ratio
$0.00
Current Ratio
$79.19

Annual earnings financials

LPTX financial data with annual/quarterly toggle

LPTX GAAP EPS - Annual & Quarterly

LPTX Sales Revenue - Annual & Quarterly

LPTX Shares Outstanding - Annual & Quarterly

Hover over bars to see exact values. Data includes up to 12 years of annual financials and up to 20 quarters of quarterly data from FMP Financial Data.

LPTX Estimated and Actual Revenue by Quarter
LPTX Estimated and Actual EPS by Quarter
LPTX Analyst Forecasts — EBITDA & EBIT
Quarter Date No of Estimates Ebitda Ebit
Low High Average Low High Average
2026-12-30 0 - - - - - -
2026-09-30 0 - - - - - -
2026-06-30 0 - - - - - -
2025-12-31 6 7.04M 7.04M 7.04M 7.04M 7.04M 7.04M
2025-09-30 12 5.8M 5.8M 5.8M 5.8M 5.8M 5.8M
2025-06-30 6 4.56M 4.56M 4.56M 4.56M 4.56M 4.56M
LPTX Analyst Forecasts — Net Income & SGA Expense
Quarter Date No of Estimates NetIncome SgaExpense
Low High Average Low High Average
2026-12-30 0 -26.44M -26.44M -26.44M - - -
2026-09-30 0 -22.91M -22.91M -22.91M - - -
2026-06-30 0 -21.15M -21.15M -21.15M - - -
2025-12-31 6 -35.25M -35.25M -35.25M 26.23M 26.23M 26.23M
2025-09-30 12 -42.3M -42.3M -42.3M 21.61M 21.61M 21.61M
2025-06-30 6 -51.12M -51.12M -51.12M 16.99M 16.99M 16.99M
LPTX Analyst Forecasts — Revenue & EPS
Quarter Date No of Revenue Estimates Revenue No of EPS Estimates EPS
Low High Average Low High Average
2026-12-30 0 - - - 1 -0.15 -0.15 -0.15
2026-09-30 0 - - - 1 -0.13 -0.13 -0.13
2026-06-30 0 - - - 1 -0.12 -0.12 -0.12
2025-12-31 6 11.73M 11.73M 11.73M 1 -0.2 -0.2 -0.2
2025-09-30 12 9.67M 9.67M 9.67M 1 -0.24 -0.24 -0.24
2025-06-30 6 7.6M 7.6M 7.6M 1 -0.29 -0.29 -0.29